UNLIMITED TURBO LONG - AMGEN | Market Closed - Deutsche Boerse AG 03:50:25 2024-06-18 pm EDT | ||
| 15.98 EUR | +1.08% |
|
| Current month | +1.08% | ||
| 1 month | -3.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 15.98 | +1.08% |
| 24-06-17 | 15.81 | +3.00% |
| 24-06-14 | 15.35 | -0.07% |
| 24-06-13 | 15.36 | -0.45% |
| 24-06-12 | 15.43 | -0.77% |
Delayed Quote Deutsche Boerse AG
Last update June 18, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PZ61RF |
| ISIN | DE000PZ61RF5 |
| Date issued | 2019-03-08 |
| Strike | 135.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.14 € |
|---|---|
| Lowest since issue | 3.77 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306
USD
Average target price
316.4
USD
Spread / Average Target
+3.42%
- Stock Market
- Certificates
- Certificat
